El Paso Public Health Officials Confirm Two Cases of Mpox in 2024

Translate to Spanish or other 102 languages!

Photo Used for Illustration Purposes. Photo by wirestock
- Advertisement -

EL PASO, Texas—The City of El Paso’s Department of Public Health (DPH) has confirmed two cases of Mpox in the community for 2024. 

The individuals, both males in their 40s, reside in the same household and are currently recovering at home. Public Health officials have launched contact tracing efforts, with the DPH epidemiology team actively working to identify close contacts and provide vaccinations as needed. 

“Mpox continues to pose a global health threat, and we urge everyone at-risk to remain vigilant in practicing preventive measures to protect themselves and their families,” said Dr. Hector Ocaranza, City-County Health Authority. “This includes safeguarding our most vulnerable community members from not only Mpox, but also other diseases like COVID-19 and the flu.”

- Advertisement -

What is Mpox?

Mpox is a viral infection that spreads between people through close, personal, often skin-to-skin contact, and can also be transmitted from certain animals to humans. It is characterized by a distinctive rash that may be painful or itchy, which can appear on various parts of the body, progressing through several stages including scabs before healing. 

Symptoms of Mpox include:

  • Distinctive rash
  • Fever
  • Chills
  • Swollen lymph nodes
  • Exhaustion
  • Muscle aches and back pain
  • Headache

Symptoms typically begin within three weeks of exposure. Some individuals may experience only a few symptoms, while others may experience the full range.

- Advertisement -

How Mpox Spreads:

Through close, personal, often skin-to-skin contact with an infected person

Through intimate physical contact, such as kissing or sexual activity

Through contact with infected wild animals via scratches, bites, or handling infected animal products

A person is contagious from the time symptoms appear until the rash has fully healed and new skin has formed. The illness typically lasts 2 to 4 weeks.

Prevention Tips:

Avoid skin-to-skin contact with anyone who has a rash that could be Mpox

Refrain from touching objects and surfaces used by someone with Mpox

Wash hands frequently with soap and water

The City currently has approximately 200 vaccines available for individuals at-risk and those identified as close contacts of confirmed cases, with more vaccines being requested to meet the community’s needs. 

Public Health officials will continue to investigate all confirmed cases and offer vaccines to those who are identified as close contacts.

Residents experiencing symptoms of Mpox should seek medical advice to receive a proper diagnosis and guidance on next steps.

For more information, please visit the City’s Mpox informational webpage (https://www.elpasotexas.gov/public-health/current-incidents/Mpox/).

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Starr County Healthcare Workforce Gets $100K Boost via New Internship Fund

Workforce Solutions (WFS) announced the launch of the $100,000 Healthcare Internship Fund, an innovative workforce development initiative designed to create structured, paid internship opportunities for 91 students pursuing high-demand healthcare careers across the region.

4th of July Fireworks Safety Guide for Parents

As families gear up for backyard barbecues, fireworks displays and other Fourth of July celebrations, safety should be part of the preparation.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.
- Advertisement -